← Coming soon·

BIOBV Biohit Oyj

OMXH · Helsinki — full main listsingle-model previewUpdated 2026-07-11

Single AI model preview (DeepSeek): Biohit Oyj estimate 5.00 € vs market price 2.68 € (+86.6%). Analyst coverage: 1. Experimental research — not investment advice.

Spot
2.68 €
Preview est.
5.00 €
Gap
+86.6%
Analysts
1
Market cap
41 M €
52-week range
2.20 €3.78 €
Sector
healthcare

About the company

Biohit Oyj, a biotechnology company, manufactures and sells bind acetaldehyde, diagnostic products, and systems for diagnostic analysis for the use of research institutions, healthcare, and industry worldwide. The company offers GastroPanel quick test NT, a rapid and quantitative immunochromatographic test for the detection of Helicobacter pylori and atrophic gastritis; GastroPanel test, a blood test for diagnosis of the function and structure of stomach mucosa; GastroSoft, a software application designed to assist clinicians and general practitioners in interpreting GastroPanel test results; and GP Reader NT for the quantitative determination of various analytes in human samples. It also provides BIOHIT active B12 (HoloTC) test, BIOHIT total 25OH vitamin D test, and BIOHIT Calprotectin; BIOHIT ColonView quick test for detection of fecal occult blood (FOB) in stool samples; BIOHIT Celiac quick test, a qualitative in vitro immunochromatographic test aiding in diagnosis of celiac disease; BIOHIT H. pylori UFT300 and H.pylori tests for the diagnosis of H,pylori infection; lactose intolerance quick test kit; and Gluten Immunogenic Peptides test. In addition, it offers Acetium acetaldeh

Source: Yahoo Finance

Model assumptions (DeepSeek)

Revenue CAGR (5y)
10.0 %
EBIT margin target
20.0 %
WACC
8.0 %
Terminal growth
2.0 %
Model confidence
60 %
The estimate runs these assumptions through the same deterministic valuation engine as the live universe. Valuation Methodology

Weekly snapshots

2.533.544.552.7.3.7.4.7.11.7.
SpotPreview est.
DateSpotPreview est.Gap
2026-07-112.68 €5.00 €+86.6%
2026-07-042.72 €4.57 €+68.0%
2026-07-032.72 €4.57 €+68.0%
2026-07-022.68 €5.02 €+87.3%
Experimental research — not investment advice. Preview estimates come from a single AI model and differ from the live 5-model consensus.